Manufacture Advanced Medicine, Supply Chain

Mastering The Complexity Of CGT Process Development - How To Meet Challenges On The Path To Commercialization

04/30/2024

sponsored by Miltenyi Biotec

Bringing cell and gene therapy (CGT) products to market is not without its challenges. In this roundtable discussion, experts will discuss how to overcome these hurdles in cell and gene process development and manufacturing and how this can help biotech companies on their way to commercial readiness.

Learn from experts discussing critical factors and solutions related to scalability, process optimization, automation and compliance, and quality assurance.

Better understanding of the ecosystem/valley of uncertainties when transitioning from early drug discovery phases towards commercial CMC (chemistry, manufacturing, and controls) preparedness.
Learn how CMC platform technologies can help to keep flexibility throughout the process discovery phase while ultimately delivering robustness towards clinical & commercial manufacturing.
Learn how to ensure scalability and consistency beyond manufacturing & QC when transitioning from small-scale to commercial-scale production
Understand key supply chain parameter and how to manage a commercial ramp-up successfully.

Available On-Demand

Email*

Choose a password*

I have read and understand the Privacy Notice *

Stay up to date with our other newsletters and sponsors information, tailored specifically to the fields you are interested in

I want to stay up to date with the "Small Molecule" field I want to stay up to date with the Cell and Gene field I want to stay up to date with the Bioprocessing field

When you click “Subscribe” we will email you a link, which you must click to verify the email address above and activate your subscription. If you do not receive this email, please contact us at [email protected].
If you wish to unsubscribe, you can update your preferences at any point.